These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19046495)

  • 1. Factors influencing treatment decisions in patients with low risk prostate cancer referred to a brachytherapy clinic.
    Taussky D; Liu A; Abrahamowicz M; Léger-Bélanger E; Bahary JP; Beauchemin MC; Nguyen TV; Donath D; Saad F
    Can J Urol; 2008 Dec; 15(6):4415-20. PubMed ID: 19046495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial.
    Wallace K; Fleshner N; Jewett M; Basiuk J; Crook J
    J Clin Oncol; 2006 Sep; 24(25):4158-62. PubMed ID: 16943531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer.
    Morris WJ; Keyes M; Palma D; Spadinger I; McKenzie MR; Agranovich A; Pickles T; Liu M; Kwan W; Wu J; Berthelet E; Pai H
    Urology; 2009 Apr; 73(4):860-5; discussion 865-7. PubMed ID: 19168203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes in younger men following permanent prostate brachytherapy.
    Shapiro EY; Rais-Bahrami S; Morgenstern C; Napolitano B; Richstone L; Potters L
    J Urol; 2009 Apr; 181(4):1665-71; discussion 1671. PubMed ID: 19233394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy for prostate cancer: external beam, brachytherapy, and salvage.
    Sailer SL
    N C Med J; 2006; 67(2):149-53. PubMed ID: 16752721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of percentage of positive prostate biopsy cores on biochemical outcome in low-risk PCa treated with brachytherapy or 3D-CRT.
    Pe ML; Trabulsi EJ; Kedika R; Pequignot E; Dicker AP; Gomella LG; Valicenti RK
    Urology; 2009 Jun; 73(6):1328-34. PubMed ID: 19376564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
    Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personality, treatment choice and satisfaction in patients with localized prostate cancer.
    Block CA; Erickson B; Carney-Doebbling C; Gordon S; Fallon B; Konety BR
    Int J Urol; 2007 Nov; 14(11):1013-8. PubMed ID: 17956529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early prostate cancer: hedonic prices model of provider-patient interactions and decisions.
    Jani AB; Hellman S
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1158-68. PubMed ID: 17881151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional treatments of localized prostate cancer.
    Zerbib M; Zelefsky MJ; Higano CS; Carroll PR
    Urology; 2008 Dec; 72(6 Suppl):S25-35. PubMed ID: 19095125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE.
    Konety BR; Cowan JE; Carroll PR;
    J Urol; 2008 May; 179(5):1797-803; discussion 1803. PubMed ID: 18343440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?
    Klein EA; Ciezki J; Kupelian PA; Mahadevan A
    Urol Oncol; 2009; 27(1):67-71. PubMed ID: 19111801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment 'mismatch' in early prostate cancer: do treatment choices take patient quality of life into account?
    Chen RC; Clark JA; Manola J; Talcott JA
    Cancer; 2008 Jan; 112(1):61-8. PubMed ID: 18040996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of localized prostate cancer].
    Vallancien G; Cathelineau X; Rozet F; Barret E
    Bull Acad Natl Med; 2008 May; 192(5):1021-6; discussion 1026. PubMed ID: 19238791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to treatment of prostate cancer through the Calgary Prostate Institute rapid access clinic.
    Kavanagh AG; Lee JC; Donnelly B
    Can J Urol; 2008 Apr; 15(2):3975-9. PubMed ID: 18405444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-surgical treatment of localised prostate cancer.
    Moule RN; Hoskin PJ
    Surg Oncol; 2009 Sep; 18(3):255-67. PubMed ID: 19442516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
    Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
    BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Brachytherapy for localised prostate cancer].
    Peiffert D
    Cancer Radiother; 2007 Nov; 11(6-7):373-8. PubMed ID: 17962060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.